Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "DEBBRAH Study - Trastuzumab Deruxtecan in Patients With HER2+/HER2-Low Advanced BC and Pathologically Confirmed Leptomeningeal Carcinomatosis"
By
Insights from 2023 SABCS
FEATURING
Marta Vaz Batista
By
Insights from 2023 SABCS
FEATURING
Marta Vaz Batista
177 views
December 18, 2023
Comments 0
Login to view comments.
Click here to Login
Videos